Press Releases

Epigenica AB Expands Presence in Japan Through Distribution Agreement with PrimeTech

Epigenica AB today announced a distribution agreement with PrimeTech Co., Ltd., bringing Epigenica’s EpiFinder™ technologies to researchers and laboratories across the Japanese market.

CellCarta Secures Global Exclusivity for Biofidelity's Aspyre® Lung to Advance Targeted Lung Cancer Testing

CellCarta and Biofidelity today announce an expanded multi-year global strategic partnership, including exclusivity for Aspyre® Lung in clinical trial settings.

ClearNote Health Appoints Jeffrey Venstrom, MD, as Chief Medical Officer and Expands Leadership Team to Drive Clinical Adoption of Early Cancer Detection Tests

The team at ClearNote Health strengthened its leadership team with four key additions.

START Partners with Trialing to Expand Access to Oncology Clinical Trials Across Europe

This partnership will enhance physician awareness of START’s portfolio of trials, streamline referrals, and support patient access to early-phase oncology research.

ELRIG Announces Prof Hazel Screen and Dr Dave Powell as Keynote Speakers for Advances in Cell-based Screening 2026

• Free-to-attend conference takes place at AstraZeneca in Gothenburg, Sweden from 6–7 May • Programme to focus on advancement of animal-replacement technologies and transition towards human-first, AI-driven drug discovery

LabConnect Expands Global Central Laboratory Infrastructure with Wuxi, China Facility

LabConnect has officially opened a new central laboratory facility in Wuxi, China, developed in collaboration with Teddy Laboratory (Frontage Laboratories). The site integrates into LabConnect’s global infrastructure to provide unified data, custom kit building, and biorepository services for multi-regional clinical trials. This expansion brings the company to eight global locations, supporting both multinational firms entering China and Asia-Pacific organizations expanding their research internationally.

University of Colorado Grants License to Cirena for RNA-Synthesis Technology

Cirena has secured a license to the University of Colorado Boulder’s patented RNA synthesis technology.

Neuland to open commercial peptide facility as part of planned phased expansion

Abselion Establishes US Subsidiary in Cambridge, MA

Supports closer engagement with scientists in North America, to meet growing international adoption of its Amperia protein quantification platform

Verista Delivers Comprehensive CSV Services to Ensure Regulatory Compliance and Data Integrity Across the Life Sciences Industry

Services provide expert-led validation, ensuring compliance, efficiency, and data integrity across systems.

Upperton Submits MHRA Licence Application for Annex 1 Sterile Manufacturing Facility Following APS Validation

Upperton has submitted its application to the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the approval of its new 7,000 sq. ft sterile manufacturing facility. The submission follows the successful execution of multiple aseptic process simulations (APS media-fill batches), completed in accordance with the revised EU GMP Annex 1 (2023) requirements.

Certara Simcyp® Simulator Results Replace Ten Human Trials for Chronic Myeloid Leukemia (CML) Therapy asciminib

Biosimulation results highlight how model-informed approaches for drug development and regulatory decision-making save time and money.

Ardena Appoints Paul Edwards as Chief People Officer

Wisdom Bioscience Establishes Scientific Advisory Board to Advance Oral Cancer Diagnostics and Screening

• Drs Giulia Kennedy, Arnold Levine, John Sninsky, Martin Goldberg and Prof Tin Tin Su join SAB • Follows close of initial funding round with investment from Stephen Quake and Jay Flatley

START Appoints Dr. Frank Smith President of its XenoSTART Preclinical Research Business Unit

Dr. Smith will strengthen XenoSTART’s position as a premier drug development partner, translating PDX-driven insights into faster, more confident oncology development decisions.

Symbiosis Appoints Joanne Anderson as Chief Commercial Officer

Quotient Sciences Extends Commercial Manufacturing Partnership for Ultra-Rare Disease Treatment

ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board

• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively

Epigenica AB Launches EpiFinder™ cNUC: The First Platform to Simultaneously Profile Multiple Histone Marks and DNA Methylation Directly from Circulating Nucleosomes in Plasma and Serum

Epigenica has announced the launch of EpiFinder™ cNUC, a unique product for liquid biopsies that significantly expands the capabilities of epigenomic research by delivering deep insights directly from circulating nucleosomes.

Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board

Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.